Visit the institution website for COVID‑19 updates
2.1 or above in BSc science subjects or engineering and medical degrees.
Months of entry
Course Directors: Professor Mimoun Azzouz, Dr Laura Ferraiuolo
This innovative and progressive course combines the research strengths of our Faculty of Medicine, Dentistry and Health, academic and industry partners, and leading international scientists. You’ll study genetic factors associated with rare inherited diseases and how gene and cell therapies can be adopted as treatment options, as well as the principles of gene and cell therapies. You'll also explore the development of specific and efficient medical treatments tailored to individual patients.
On our MSc, you'll develop essential skills for each step of the translational pathway of cell and gene therapy products, including: discovery, vector design, GLP pre-clinical regulatory studies, GMP manufacturing and analytics, process innovation, quality control, qualified person (QP), safety, clinical design, commercialisation and market authorisation.
The course will provide you with up-to-date knowledge of advances in the field, offering a comprehensive road map on the required steps to take an advanced therapy project from discovery to clinical trial and then marketing authorisation.
Please see our University website for the most up-to-date course information: https://www.sheffield.ac.uk/postgraduate/taught/courses
Information for international students
Overall IELTS score of 7.0 with a minimum of 6.5 in each component, or equivalent.
For more information about entry requirements for international students, please visit our website.
Qualification, course duration and attendance options
- full time12 months
- Campus-based learningis available for this qualification
Course contact details
- Postgraduate Admissions Tutor